Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Edward L. Snyder"'
Autor:
Edward L. Snyder, Michael E. Sekela, Ian J. Welsby, Yoshiya Toyoda, Mohamed Alsammak, Neel R. Sodha, Thomas M. Beaver, J. Peter R. Pelletier, James D. Gorham, John S. McNeil, Roman M. Sniecinski, Ronald G. Pearl, Gregory A. Nuttall, Ravi Sarode, T. Brett Reece, Alesia Kaplan, Robertson D. Davenport, Tina S. Ipe, Peyman Benharash, Ileana Lopez-Plaza, Richard R. Gammon, Patrick Sadler, John P. Pitman, Kathy Liu, Stanley Bentow, Laurence Corash, Nina Mufti, Jeanne Varrone, Richard J. Benjamin, for the ReCePI study group
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Red blood cell (RBC) transfusion is a critical supportive therapy in cardiovascular surgery (CVS). Donor selection and testing have reduced the risk of transfusion-transmitted infections; however, risks remain from bacteria, emerg
Externí odkaz:
https://doaj.org/article/6afcdc33fc664ea1b6806a81a0f891ba
Autor:
Christopher A. Kerantzas, Jacob Merwede, Edward L. Snyder, Jeanne E. Hendrickson, Christopher A. Tormey, Barbara I. Kazmierczak, David R. Peaper
Publikováno v:
Transfusion. 62:2458-2463
In 2019 the Centers for Disease Control and Prevention (CDC) reported a series of 4 transfusion reactions that resulted from contamination of apheresis platelet products. Products involved in all 4 cases were contaminated with Acinetobacter calcoacet
Publikováno v:
Rossi's Principles of Transfusion Medicine. :489-500
Publikováno v:
Rossi's Principles of Transfusion Medicine. :306-313
Autor:
Edward L. Snyder, Allison P. Wheeler, Majed Refaai, Claudia S. Cohn, Jessica Poisson, Magali Fontaine, Mary Sehl, Ajay K. Nooka, Lynne Uhl, Philip Spinella, Maly Fenelus, Darla Liles, Thomas Coyle, Joanne Becker, Michael Jeng, Eric A. Gehrie, Bryan R. Spencer, Pampee Young, Andrew Johnson, Jennifer J. O'Brien, Gary J. Schiller, John D. Roback, Elizabeth Malynn, Ronald Jackups, Scott T. Avecilla, Jin‐Sying Lin, Kathy Liu, Stanley Bentow, Ho‐Lan Peng, Jeanne Varrone, Richard J. Benjamin, Laurence M. Corash
Publikováno v:
Transfusion, vol 62, iss 7
BackgroundPlatelet transfusion carries risk of transfusion-transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion-related acute lung injury and ac
Publikováno v:
Practical Transfusion Medicine. :620-631
Publikováno v:
Hematology/Oncology Clinics of North America. 33:749-766
In the past 30 years, transfusion safety has increased substantially and blood transfusion is now a safer procedure than at any time in the past. Herein, we provide a comprehensive review of pathogen reduction, which is the new paradigm in transfusio
Autor:
Bryan R. Spencer, Eric A. Gehrie, Edward L. Snyder, Wade L. Schulz, Amit Gokhale, Burak Bahar
Publikováno v:
British Journal of Haematology
Summary Pathogen‐reduced (PR) platelets are routinely used in many countries. Some studies reported changes in platelet and red blood cell (RBC) transfusion requirements in patients who received PR platelets when compared to conventional (CONV) pla
Autor:
Edward L. Snyder, Wade L. Schulz, Nathaniel Price, Rebecca Ross, Eric A. Gehrie, Amit Gokhale, Burak Bahar, Bryan R. Spencer, Jacob McPadden
Publikováno v:
The Journal of Pediatrics. 209:220-225
To assess the safety and efficacy of a Food and Drug Administration-approved pathogen-reduced platelet (PLT) product in children, as ongoing questions regarding their use in this population remain.We report findings from a quality assurance review of
Autor:
Rebecca L. Olin, Bryan R. Spencer, Zhanna Kaidarova, Edward L. Snyder, Joan F. Hilton, Elizabeth St. Lezin, Lirong Qu, Matthew S. Karafin, Roberta Bruhn, Nhlbi Recipient Epidemiology, Edward L. Murphy
Publikováno v:
Qual Life Res
PURPOSE: Outpatients with hematologic disease often receive red cell transfusion to treat anemia and fatigue. The effect of transfusion on fatigue-related quality of life and how well this effect is sustained has not been quantified. The study aim wa